Clinical Trial of SP-2577 in Patients With Relapsed or Refractory Ewing Sarcoma
Condition: Ewing Sarcoma Intervention: Drug: SP-2577 Sponsor: Salarius Pharmaceuticals, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2018 Category: Research Source Type: clinical trials